BWL
ARKG icon

Bogart Wealth LLC’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bogart Wealth LLC’s Portfolio ARKG Stock Details ARKG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-100
Closed -$2.88K – 1122
2024
Q1 		$2.88K Hold
100
– – ﹤0.01% 861
2023
Q4 		$3.28K Sell
100
-16
-14% -$435 ﹤0.01% 827
2023
Q3 		$3.23K Buy
116
+16
+16% +$523 ﹤0.01% 810
2023
Q2 		$3.41K Hold
100
– – ﹤0.01% 799
2023
Q1 		$3.01K Hold
100
– – ﹤0.01% 836
2022
Q4 		$2.82K Sell
100
-21
-17% -$666 ﹤0.01% 760
2022
Q3 		$4K Hold
121
– – ﹤0.01% 708
2022
Q2 		$4K Buy
+121
New +$4.23K ﹤0.01% 656
2021
Q3 		– Sell
-40
Closed -$4K – 719
2021
Q2 		$4K Buy
+40
New +$3.4K ﹤0.01% 532

Other funds holding ARKG

MMEA
Main Management ETF Advisors San Francisco, California $2.68B AUM 24.27% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Bogart Wealth LLC's ARKG Position: Q2 2024 in Review

Bogart Wealth LLC sold out of ARK Genomic Revolution ETF (ARKG) in Q2 2024, closing a stake of 100 shares — an estimated $2.88K sold.

Bogart Wealth LLC first reported a position in ARKG in Q2 2021 and held it in 9 quarters. The position peaked at $4K in Q3 2022. 261 funds tracked by Wall St. Rank hold ARKG as of Q2 2024.

  • Bogart Wealth LLC reported no remaining ARK Genomic Revolution ETF position as of Q2 2024 after selling out during the quarter.
  • Bogart Wealth LLC sold 100 ARK Genomic Revolution ETF shares in Q2 2024, an estimated $2.88K.
  • Bogart Wealth LLC first reported a position in ARK Genomic Revolution ETF in Q2 2021 and held it in 9 quarters.
  • Bogart Wealth LLC's ARK Genomic Revolution ETF position peaked at $4K in Q3 2022.
  • 261 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2024.

Based on Bogart Wealth LLC's 13F filing for Q2 2024, filed 31 Jul 2024.